Latest News

Gene therapy IL-12 clinical trial

JAFRAL is proud to be a GMP manufacturing partner of a consortium/project for first clinical trial on combined electrochemotherapy with gene therapy with Interleukin-12 (IL-12) to improve/enhance local and systemic response to skin tumor treatment.

Competence Center Bio-Pharm

As of June 1 2018 JAFRAL is a part of Bio-Pharm Competence Center for Biotechnology and Pharmaceuticals.

Phage Therapy & Antibiotic Resistance 2018

JAFRAL is going to attend and held presentation at Phage Therapy & Antibiotic Resistance 2018 in Florence, Italy. You are welcome to meet with our representative at the conference dr. Frenk Smrekar

Load More Posts